医学
奥曲肽
胰腺炎
急性胰腺炎
内科学
随机对照试验
出版偏见
腹痛
内镜逆行胰胆管造影术
胃肠病学
相对风险
荟萃分析
外科
生长抑素
置信区间
作者
Ahmad Hormati,Asma Mousavi,Shayan Shojaei,Sanaz Bordbar,Atie Moghtadaei,Hediyeh Alemi,Sadaf G Sepanlou,Amir Kasaeian
标识
DOI:10.1097/mcg.0000000000002224
摘要
Octreotide appears to be effective in reducing the risk of overall and moderate PEP. However, its impact on mild and severe PEP remains inconclusive. Further large-scale, high-quality RCTs are needed to refine clinical recommendations regarding its routine prophylactic use in ERCP.
科研通智能强力驱动
Strongly Powered by AbleSci AI